PEAK6 Investments’s iShares Biotechnology ETF IBB Stock Holding History

PEAK6 Investments’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-927	Closed	-$134K	–	3739
2024 Q2	$127K	Buy	+927	New	+$124K	﹤0.01%	2945
2023 Q2	–	Sell	-33,695	Closed	-$4.38M	–	4248
2023 Q1	$4.35M	Buy	33,695 +1,757	+6%	+$230K	0.02%	786
2022 Q4	$4.19M	Buy	+31,938	New	+$4.13M	0.02%	819
2022 Q1	–	Sell	-4,931	Closed	-$642K	–	5547
2021 Q4	$753K	Buy	+4,931	New	+$763K	﹤0.01%	2823
2021 Q3	–	Sell	-5	Closed	-$841	–	5419
2021 Q2	$1K	Buy	+5	New	+$770	﹤0.01%	4952
2019 Q4	–	Sell	-8,976	Closed	-$893K	–	3690
2019 Q3	$893K	Sell	8,976 -30,374	-77%	-$3.18M	0.01%	1854
2019 Q2	$4.29M	Buy	+39,350	New	+$4.19M	0.03%	800
2018 Q4	–	Sell	-17,290	Closed	-$1.84M	–	4278
2018 Q3	$2.11M	Buy	+17,290	New	+$2.04M	0.01%	1394

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

PEAK6 Investments's IBB Position: Q3 2024 in Review

PEAK6 Investments sold out of iShares Biotechnology ETF (IBB) in Q3 2024, closing a stake of 927 shares — an estimated $134K sold.

PEAK6 Investments first reported a position in IBB in Q3 2018 and held it in 8 quarters. The position peaked at $4.35M in Q1 2023. 893 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

PEAK6 Investments reported no remaining iShares Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
PEAK6 Investments sold 927 iShares Biotechnology ETF shares in Q3 2024, an estimated $134K.
PEAK6 Investments first reported a position in iShares Biotechnology ETF in Q3 2018 and held it in 8 quarters.
PEAK6 Investments's iShares Biotechnology ETF position peaked at $4.35M in Q1 2023.
893 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.